UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 270

Sortiert nach

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases

Annals of oncology, 2018-04, Vol.29 (4), p.959-965

2018

Link zum Volltext

Verfügbarkeit prüfen

NSCLC, metastatic CheckMate 026: A phase 3 trial of nivolumab vs investigator's choice (IC) of platinum-based doublet chemotherapy (PT-DC) as first-line therapy for stage iv/recurrent programmed death ligand 1 (PD-L1)−positive NSCLC

Annals of oncology, 2016-10, Vol.27, p.vi577-vi577

2016

Link zum Volltext

Verfügbarkeit prüfen

Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis

Annals of oncology, 2023-02, Vol.34 (2), p.173-185

2023

Link zum Volltext

Verfügbarkeit prüfen

The Relationship Between Reported Daily Nicotine Dose from NRT and Daily Cigarette Consumption in Pregnant Women Who Smoke in an Observational Cohort Study

Nicotine & tobacco research, 2024-01, Vol.26 (2), p.212-219

2024

Link zum Volltext

Verfügbarkeit prüfen

A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations

ESMO open, 2023-04, Vol.8 (2), p.101183-101183, Article 101183

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 Dose-Escalation Study of Accelerated Fractionation and Concurrent Chemotherapy for Locally Advanced Lung Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S87-S87

2015

Link zum Volltext

Verfügbarkeit prüfen

Anti-PD-1 Therapy and Stereotactic Radiation for Melanoma and Non-Small Cell Lung Cancer Patients with Brain Metastases: A 2-Institution Series

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E97-E98

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 Dose Escalation Study of Accelerated Fractionation and Concurrent Chemotherapy Using Intensity Modulated Radiation Therapy for Locally Advanced Lung Cancer

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S213-S214

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of Concurrent Chemoradiation on T Cell Populations in Patients With Advanced-Stage Oropharyngeal Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2014-02, Vol.88 (2), p.504-504

2014

Link zum Volltext

Verfügbarkeit prüfen

First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

The New England journal of medicine, 2017-06, Vol.376 (25), p.2415-2426

2017

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

The New England journal of medicine, 2015-10, Vol.373 (17), p.1627-1639

2015

Link zum Volltext

Verfügbarkeit prüfen

P-Selectin Induces the Expression of Tissue Factor on Monocytes

Proceedings of the National Academy of Sciences - PNAS, 1994-09, Vol.91 (19), p.8767-8771

1994

Link zum Volltext

Verfügbarkeit prüfen

Twenty Year Experience with Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of the Oropharynx

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S503-S504

2011

Link zum Volltext

Verfügbarkeit prüfen

B-059 Allergen-specific IgE Measurement for Peanut Ara h 2

Clinical chemistry (Baltimore, Md.), 2023-09, Vol.69 (Supplement_1)

2023

Link zum Volltext

Verfügbarkeit prüfen

P27.04 Clinical Outcomes for Patients With Stage III NSCLC and STK11 or KEAP1 Genetic Alterations

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1042-S1042

2021

Link zum Volltext

Verfügbarkeit prüfen

Synchronous Chemoradiation and Multiple Targeted Drugs for Advanced Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S175-S176

2009

Link zum Volltext

Verfügbarkeit prüfen

Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV)

Annals of surgical oncology, 2001-09, Vol.8 (8), p.644-650

2001

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic Radiotherapy for Malignancies Involving the Trigeminal and Facial Nerves

Technology in cancer research & treatment, 2012-06, Vol.11 (3), p.221-228

2012

Link zum Volltext

Verfügbarkeit prüfen

1664TiP A phase II randomized study of BMS-986012, an anti-fucosyl-GM1 monoclonal antibody, plus carboplatin, etoposide, and nivolumab (NIVO) as first-line (1L) therapy in patients with extensive-stage small cell lung cancer (ES-SCLC)

Annals of oncology, 2021-09, Vol.32, p.S1170-S1170

2021

Link zum Volltext

Verfügbarkeit prüfen

P2.04-89 Neoadjuvant Pembrolizumab in Early Stage Non-Small Cell Lung Cancer (NSCLC): Toxicity, Efficacy, and Surgical Outcomes

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S745-S745

2019

Link zum Volltext

Verfügbarkeit prüfen

CheckMate 817 : nivolumab + ipilimumab en première ligne chez des patients atteints d’un cancer bronchique non à petites cellules (CBNPC) avancé avec un ECOG PS 2 et autres populations particulières

Revue des maladies respiratoires actualités, 2020-01, Vol.12 (1), p.206-207

2020

Link zum Volltext

Verfügbarkeit prüfen

Résultats à 5 ans des essais cliniques randomisés de phase III CheckMate (CM) 017/057 : nivolumab vs docétaxel dans le cancer bronchique non à petites cellules (CBNPC) avancé après un traitement antérieur

Revue des maladies respiratoires actualités, 2020-01, Vol.12 (1), p.208-209

2020

Link zum Volltext

Verfügbarkeit prüfen

41P Efficacy of first-line (1L) nivolumab (N) + ipilimumab (I) by tumor histologic subtype in patients (pts) with metastatic nonsquamous NSCLC (mNSQ-NSCLC)

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S64-S65

2023

Link zum Volltext

Verfügbarkeit prüfen

Radiofrequency Ablation Followed by Conventional Radiotherapy for Medically Inoperable Stage I Non-small Cell Lung Cancer

Chest, 2006-03, Vol.129 (3), p.738-745

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 270

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(234)
Mit Volltextzugriff
(235)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(129)
Life Sciences & Biomedicine
(105)
Humans
(83)
Female
(59)
Male
(54)
Biological And Medical Sciences
(53)
Medical Sciences
(41)
Adult
(37)
Middle Aged
(37)
Aged
(28)
Animals
(27)
Oncology
(26)
Technology
(19)
Fundamental And Applied Biological Sciences. Psychology
(18)
Physical Sciences
(17)
Surgery
(14)
Treatment Outcome
(13)
Combined Modality Therapy
(11)
Engineering
(11)
General & Internal Medicine
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases

NSCLC, metastatic CheckMate 026: A phase 3 trial of nivolumab vs investigator's choice (IC) of platinum-based doublet chemotherapy (PT-DC) as first-line therapy for stage iv/recurrent programmed death ligand 1 (PD-L1)−positive NSCLC

Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis

Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study

The Relationship Between Reported Daily Nicotine Dose from NRT and Daily Cigarette Consumption in Pregnant Women Who Smoke in an Observational Cohort Study

A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations

Phase 1 Dose-Escalation Study of Accelerated Fractionation and Concurrent Chemotherapy for Locally Advanced Lung Cancer

Anti-PD-1 Therapy and Stereotactic Radiation for Melanoma and Non-Small Cell Lung Cancer Patients with Brain Metastases: A 2-Institution Series

Phase 1 Dose Escalation Study of Accelerated Fractionation and Concurrent Chemotherapy Using Intensity Modulated Radiation Therapy for Locally Advanced Lung Cancer

Impact of Concurrent Chemoradiation on T Cell Populations in Patients With Advanced-Stage Oropharyngeal Squamous Cell Carcinoma

First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

P-Selectin Induces the Expression of Tissue Factor on Monocytes

Twenty Year Experience with Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of the Oropharynx

B-059 Allergen-specific IgE Measurement for Peanut Ara h 2

P27.04 Clinical Outcomes for Patients With Stage III NSCLC and STK11 or KEAP1 Genetic Alterations

Synchronous Chemoradiation and Multiple Targeted Drugs for Advanced Head and Neck Cancer

Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV)

Stereotactic Radiotherapy for Malignancies Involving the Trigeminal and Facial Nerves

1664TiP A phase II randomized study of BMS-986012, an anti-fucosyl-GM1 monoclonal antibody, plus carboplatin, etoposide, and nivolumab (NIVO) as first-line (1L) therapy in patients with extensive-stage small cell lung cancer (ES-SCLC)

P2.04-89 Neoadjuvant Pembrolizumab in Early Stage Non-Small Cell Lung Cancer (NSCLC): Toxicity, Efficacy, and Surgical Outcomes

CheckMate 817 : nivolumab + ipilimumab en première ligne chez des patients atteints d’un cancer bronchique non à petites cellules (CBNPC) avancé avec un ECOG PS 2 et autres populations particulières

Résultats à 5 ans des essais cliniques randomisés de phase III CheckMate (CM) 017/057 : nivolumab vs docétaxel dans le cancer bronchique non à petites cellules (CBNPC) avancé après un traitement antérieur

41P Efficacy of first-line (1L) nivolumab (N) + ipilimumab (I) by tumor histologic subtype in patients (pts) with metastatic nonsquamous NSCLC (mNSQ-NSCLC)

Radiofrequency Ablation Followed by Conventional Radiotherapy for Medically Inoperable Stage I Non-small Cell Lung Cancer

Suchergebnisse filtern